Abstract:Introduction: Vitamin D-binding protein (VDBP) is correlated with nonalcoholic fatty liver disease (NAFLD) through the biological functions of regulating plasma vitamin D (VD) level and the inflammatory process. Objective: This study aims to investigate the effects of VD level and VDBP gene polymorphisms on the risk of NAFLD in a Chinese population. Methods: Plasma 25-hydroxyvitamin D 3 levels were measured and seven VDBP candidate genetic variants (rs222020, rs2282679, rs4588, rs1155563, rs7041, rs16847024, rs3733359) were genotyped among participants in this case-control study. The control group was frequency-matched to the NAFLD case group by age and gender. Correlation analysis and multiple linear regressions were used to screen determinants of 25-hydroxyvitamin D 3 levels. Multivariable unconditional logistic regression was performed to estimate odds ratio (OR) and 95% confidence interval (95% CI). The prediction capability of models containing independent factors was estimated by the area under the receiver operating characteristic curve and Hosmer-Lemeshow test. Results: Age, body mass index, and triacylglycerol were independent factors influencing VD levels. Participants with low VD levels had significantly higher prevalence of NAFLD compared to subjects with normal VD levels ( p < 0.001). A low VD level contributed to increased the risk of NAFLD, independent of metabolic factors known to affect VD levels (adjusted OR = 2.282, 95% CI = 1.422–3.661, p = 0.001). Logistic regression analysis showed that individuals carrying rs7041-G allele had a significantly decreased the risk of NAFLD occurrence compared to T allele (additive model: adjusted OR = 0.814, 95% CI = 0.713–0.929, p = 0.002; codominant model: adjusted OR = 0.623, 95% CI = 0.449–0.866, p = 0.005), after adjusting for age, gender, and overweight. Stratification by multiple metabolic disorders did not alter this relationship. Moreover, we developed a simple model including age, gender, metabolic disorders, and VDBP single nucleotide polymorphism (SNP) to assess NAFLD risk, an AUC of which being 0.817, significantly higher than the model not included VDBP SNP, with Hosmer-Lemeshow test fitting well ( p = 0.182). Conclusions: Low plasma VD levels may increase susceptibility to NAFLD, while rs7041-G allele in VDBP contributed to a decreased NAFLD risk among Chinese population. The VDBP variant significantly improved the capability for NAFLD risk assessment, which could be used for early screening and management of NAFLD.

The HSD17B13 rs72613567 variant is associated with lower levels of albuminuria in patients with biopsy-proven nonalcoholic fatty liver disease

Genetic variation of HSD17B13 is associated with an increased risk of lean nonalcoholic fatty liver disease

Association of HSD17B13 Rs72613567: TA Allelic Variant with Liver Disease: Review and Meta-Analysis

High Risk of Fatty Liver Disease Amplifies the Alanine Transaminase–Lowering Effect of a HSD17B13 Variant

The Association of Low‐grade Albuminuria with Incident Nonalcoholic Fatty Liver Disease and Non‐invasive Markers of Liver Fibrosis by Glycemic Status

Sirtuin3 rs28365927 functional mutation confers to the high risk of non-alcoholic fatty liver disease in Chinese Han population

Nonalcoholic Fatty Liver Disease is Associated with Low-Grade Albuminuria in Chinese Adults (change Not Displayed)

PNPLA3 Rs738409 is Associated with Renal Glomerular and Tubular Injury in NAFLD Patients with Persistently Normal ALT Levels

Vascular inflammation, atherosclerosis, and lipid metabolism and the occurrence of non-high albuminuria diabetic kidney disease: A cross-sectional study

The association of low‐grade albuminuria with incident non‐alcoholic fatty liver disease and non‐invasive markers of liver fibrosis by glycaemia status

Associations between genetic variants of HSD17B13 and fasting plasma glucose in Chinese children

Expression and localization of HSD17B13 along mouse urinary tract

Influences of Vitamin D Levels and Vitamin D-Binding Protein Polymorphisms on Nonalcoholic Fatty Liver Disease Risk in a Chinese Population

Arg913Gln of SLC12A3 Gene Promotes Development and Progression of End-Stage Renal Disease in Chinese Type 2 Diabetes Mellitus

U-shaped association between serum albumin and development of chronic kidney disease in general hypertensive patients

Causal effects from non‐alcoholic fatty liver disease on kidney function: A Mendelian randomization study

The association between rs1260326 with the risk of NAFLD and the mediation effect of triglyceride on NAFLD in the elderly Chinese Han population

Genetic Polymorphism of Vitamin D Family Genes <i>CYP2R1</i>, <i>CYP24A1</i>, and <i>CYP27B1</i> Are Associated With a High Risk of Non-alcoholic Fatty Liver Disease: A Case-Control Study

The Single Nucleotide Polymorphism Rs499765 is Associated with Fibroblast Growth Factor 21 and Nonalcoholic Fatty Liver Disease in a Chinese Population with Normal Glucose Tolerance.

Metabolic Syndrome but Not Fatty Liver-Associated Genetic Variants Correlates with Glomerular Renal Function Decline in Patients with Non-Alcoholic Fatty Liver Disease

Association of Rs5764455 and Rs6006473 Polymorphisms in PARVB with Liver Damage of Nonalcoholic Fatty Liver Disease in Han Chinese Population